The case against universal WBC reduction (and for the practice of evidence-based medicine)
- 1 December 2000
- journal article
- editorial
- Published by Wiley in Transfusion
- Vol. 40 (12) , 1522-1527
- https://doi.org/10.1046/j.1537-2995.2000.40121522.x
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Transfusion‐associated immunomodulation and universal white cell reduction: are we putting the cart before the horse?Transfusion, 1999
- Guidelines on the clinical use of leucocyte‐depleted blood componentsTransfusion Medicine, 1998
- Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet TransfusionsNew England Journal of Medicine, 1997
- Prevalence of Platelet Transfusion Reactions Before and After Implementation of Leukocyte-Depleted Platelet Concentrates by FiltrationVox Sanguinis, 1993
- Prevention of alloimmunization in patients with acute leukemia by use of white cell‐reduced blood components—a randomized trialTransfusion, 1991
- Febrile reactions after platelet transfusion: the effect of single versus multiple donorsTransfusion, 1990
- Use of leucocyte‐poor blood components and HLA‐matched‐platelet donors to prevent HLA alloimmunizationBritish Journal of Haematology, 1986
- CONTROLLED TRIAL OF TREATMENT OF RECURRENT SPONTANEOUS ABORTION BY IMMUNISATION WITH PATERNAL CELLSThe Lancet, 1985
- Febrile Transfusion Reaction: What Blood Component Should Be Given Next?Vox Sanguinis, 1982
- Improvement of Kidney-Graft Survival with Increased Numbers of Blood TransfusionsNew England Journal of Medicine, 1978